3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
6
Phase NA
2
Phase 4
1
Phase 1/2
1
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Tuberous Sclerosis
1
Lymphangioleiomyomatosis
1
Interventions
Cyclophosphamide
143
pembrolizumab
126
Nivolumab
114
Carboplatin
99
Dexamethasone
93
Rituximab
91
Paclitaxel
87
Gemcitabine
85
Lenalidomide
75
Cytarabine
74
Radiotherapy
72
Cisplatin
70
Bevacizumab
64
Etoposide
62
fludarabine phosphate
58
fludarabine
56
Docetaxel
54
Bortezomib
54
Ipilimumab
53
Prednisone
49
Doxorubicin
48
Temozolomide
47
Everolimus
46
Erlotinib Hydrochloride
46
Fluorouracil
44
Azacitidine
44
Capecitabine
43
Calcium Dobesilate
43
Filgrastim
42
Melphalan
41
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1/2
×
Has results
×
Simvastatin
×
Clear all
NCT02061397
2020-08-25
SOS
University of Pennsylvania
Phase 1/2
Completed
10 enrolled
6 charts